These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 6765278)

  • 21. Treatment of portal hypertension with nadolol in patients with liver cirrhosis.
    Cervera J; Torres-Zamora M; Gutiérrez-Carreño R; Fierro M; Schaeffer L; Landa L
    Arch Invest Med (Mex); 1983; 14(4):331-41. PubMed ID: 6678555
    [No Abstract]   [Full Text] [Related]  

  • 22. Effect of short-term and long-term treatment with metoprolol on renal blood flow and glomerular filtration rate in hypertensive patients with a normal kidney function.
    Strandgaard S; Elmgreen J; Christensen TE; Laursen SW
    Dan Med Bull; 1982 Oct; 29(6):287-9. PubMed ID: 7140383
    [No Abstract]   [Full Text] [Related]  

  • 23. [Comparative study of the combination of chlorthalidone with verapamil and metoprolol in arterial hypertension: evaluation by cycloergometrics].
    Candau LA; Pereira LS; Scherr C
    Arq Bras Cardiol; 1981 Aug; 37(2):133-8. PubMed ID: 6753801
    [No Abstract]   [Full Text] [Related]  

  • 24. [Hemodynamic changes caused by beta-blocking agents with and without intrinsic sympathicomimetic activity and with and without cardioselective activity. Comparison of hypertensives at fixed and variable frequencies].
    Mattioli G; Ricci S; Menozzi A; Teglio V
    Minerva Cardioangiol; 1982 Mar; 30(3):81-8. PubMed ID: 6123962
    [No Abstract]   [Full Text] [Related]  

  • 25. Hydrochlorothiazide and nadolol in the treatment of hypertension.
    Olerud B
    Practitioner; 1982 Apr; 226(1366):785-7. PubMed ID: 7045854
    [No Abstract]   [Full Text] [Related]  

  • 26. [Clinical evaluation of the hypotensive effects of nadolol].
    Hanzlik J; Sodolski W; Stelmasiak T; Wolański I
    Kardiol Pol; 1982; 25(2):101-6. PubMed ID: 6125620
    [No Abstract]   [Full Text] [Related]  

  • 27. [Effect of salbutamol, indomethacin and atenolol on plasma renin activity in patients with essential arterial hypertension].
    Stornello M; Di Rao G; Iachello M; Bosco V; Pantano S; Pisani R; Scapellato L
    Minerva Nefrol; 1982; 29(3):159-64. PubMed ID: 6292792
    [No Abstract]   [Full Text] [Related]  

  • 28. [The effect of visken and hypothiazide on the indices of the central and renal hemodynamics in patients with atherosclerotic hypertension].
    Shishkina OS
    Vrach Delo; 1990 Apr; (4):41-3. PubMed ID: 2275163
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of the antihypertensive and renal effects of tertatolol and nadolol in hypertensive patients with mild renal impairment.
    Fallo F; Gregianin M; Bui F; Macrì C; Folino P; Mantero F
    Eur J Clin Pharmacol; 1991; 40(3):309-11. PubMed ID: 1676368
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of nadolol in treatment of hypertension.
    Volicer L; Liang CS; Gavras H; Tifft CP; Kershaw GR; Gavras I; Griffith DL; Vukovitch R; Brunner HR
    J Clin Pharmacol; 1979; 19(2-3):137-47. PubMed ID: 33998
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prolonged bradycardia after neostigmine administration in a patient taking nadolol.
    Seidl DC; Martin DE
    Anesth Analg; 1984 Mar; 63(3):365-7. PubMed ID: 6703355
    [No Abstract]   [Full Text] [Related]  

  • 32. [Use of Cordanum in labile hypertension].
    Gerasimiuk PP; Zaporozhets TF; Slobodianik GP
    Vrach Delo; 1982 Nov; (11):29-30. PubMed ID: 6130655
    [No Abstract]   [Full Text] [Related]  

  • 33. Dose-ranging study of the new beta-adrenergic antagonist nadolol in the treatment of essential hypertension.
    Frithz G
    Curr Med Res Opin; 1978; 5(5):383-7. PubMed ID: 26519
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Redistribution of cardiac output to the kidneys during oral nadolol administration.
    Textor SC; Fouad FM; Bravo EL; Tarazi RC; Vidt DG; Gifford RW
    N Engl J Med; 1982 Sep; 307(10):601-5. PubMed ID: 7110207
    [No Abstract]   [Full Text] [Related]  

  • 35. [Efficacy of atenolol in moderate-to-mild essential hypertension and in ischemic cardiopathy. Evaluation with the bicycle ergometer].
    Mellini M; Robutti A; Mattiauda C; Cavazzana G; Roych C; Sanfelici D; Baccino M; Reforzo F
    Clin Ter; 1983 Mar; 104(5):391-4. PubMed ID: 6851445
    [No Abstract]   [Full Text] [Related]  

  • 36. Antihypertensive effects of bunitrolol in essential hypertension.
    Yoshimura M; Shikuma R; Takashina R; Takeda K; Takahashi H; Ijichi H; Kajita Y; Yamazaki H
    Arzneimittelforschung; 1983; 33(8):1181-4. PubMed ID: 6139114
    [No Abstract]   [Full Text] [Related]  

  • 37. Long-acting beta-blockers in the twenty-fourth hour. A comparison in hypertension.
    Hackett GI; Harrison P; Kershaw S
    Practitioner; 1981 May; 225(1355):752-5. PubMed ID: 7027230
    [No Abstract]   [Full Text] [Related]  

  • 38. [Effect of nadolol on central and regional hemodynamics in arterial hypertension].
    Gumbatov NB; Kasumova FZ; Mustafaev II; Sevdimov ID; Mamedova RN
    Sov Med; 1990; (7):112. PubMed ID: 2251552
    [No Abstract]   [Full Text] [Related]  

  • 39. [Nadolol + bendroflumethiazide in a fixed combination and in sequential administration. Experimental research on antihypertensive efficacy and tolerability].
    Del Re ML; Ricci A; Abate G
    Clin Ter; 1986 Mar; 116(5):385-90. PubMed ID: 2871962
    [No Abstract]   [Full Text] [Related]  

  • 40. [Effect of oxprenolol on the plasma renin activity in essential arterial hypertension].
    Cospite M; Lo Presti T; Ferrara F; Mineo R
    Boll Soc Ital Cardiol; 1977; 22(3):335-9. PubMed ID: 617279
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.